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Abstract
Background:  One of the most neglected areas of biomedical Text Mining (TM) is the
development of systems based on carefully assessed user needs. We have recently investigated the
user needs of an important task yet to be tackled by TM -- Cancer Risk Assessment (CRA). Here
we take the first step towards the development of TM technology for the task: identifying and
organizing the scientific evidence required for CRA in a taxonomy which is capable of supporting
extensive data gathering from biomedical literature.
Results:  The taxonomy is based on expert annotation of 1297 abstracts downloaded from
relevant PubMed journals. It classifies 1742 unique keywords found in the corpus to 48 classes
which specify core evidence required for CRA. We report promising results with inter-annotator
agreement tests and automatic classification of PubMed abstracts to taxonomy classes. A simple
user test is also reported in a near real-world CRA scenario which demonstrates along with other
evaluation that the resources we have built are well-defined, accurate, and applicable in practice.
Conclusion: We present our annotation guidelines and a tool which we have designed for expert
annotation of PubMed abstracts. A corpus annotated for keywords and document relevance is also
presented, along with the taxonomy which organizes the keywords into classes defining core
evidence for CRA. As demonstrated by the evaluation, the materials we have constructed provide
a good basis for classification of CRA literature along multiple dimensions. They can support
current manual CRA as well as facilitate the development of an approach based on TM. We discuss
extending the taxonomy further via manual and machine learning approaches and the subsequent
steps required to develop TM technology for the needs of CRA.
Background
Biomedical Text Mining (TM) has become increasingly
popular due to the great need to provide access to the tre-
mendous body of texts available in biomedical sciences.
Considerable progress has been made in the development
of basic resources (e.g. ontologies, annotated corpora)
and techniques in this area, e.g. in Information Retrieval
(IR) (i.e. identification of relevant documents) and Infor-
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mation Extraction (IE) (i.e. identification of specific infor-
mation in the documents, e.g. proteins and genes, and
specific relations between them), and research has began
to focus on increasingly challenging tasks, e.g. summari-
zation and the discovery of novel information in biomed-
ical literature [1-4].
The major current challenge is to extend TM techniques
with richer and deeper analysis and to apply them to sup-
port real-world tasks in biomedicine. In recent past, there
has been an increasing trend towards research which is
driven by actual user needs rather than by technical devel-
opments [5]. Corpus annotation and classification
schemes applicable to a wider variety of biomedical liter-
ature have been developed to support biologists with
diverse TM needs [6,7]. Shared tasks (e.g. BioCreative and
the TREC Genomics track) targeting the actual workflow
of biomedical researchers have appeared, along with stud-
ies exploring the TM needs of specific tasks (e.g. literature
curation, library services for biomedical applications)
[8,9]. Several practical tools have been developed for the
use of working scientists which can support IR and IE
from biomedical literature [10-13]. However, the under-
standing of user needs is still one of the neglected areas of
biomedical TM, and further user-centered evaluations and
systems grounded in real-life tasks are required to deter-
mine which tools and services are actually useful [14].
In our recent work, we investigated the user needs of a
challenging task yet to be tackled by text mining: Cancer
Risk Assessment (CRA) [15,16]. CRA is a task which
involves examining existing published evidence to deter-
mine the relationship between exposure to a chemical and
the likelihood of developing cancer from that exposure
[17]. It has become increasingly important over the past
years as the link between environmental chemicals and
cancer has become evident and tight legislations govern-
ing chemical safety have been introduced worldwide. For
example, the recently established European Community
REACH (Registration, Evaluation, Authorisation and
Restriction of Chemical substances) legislation requires
that all the chemicals manufactured or imported in a high
quantity must undergo thorough CRA (EC 1907/2006)
[18].
Performed manually by experts in health related institu-
tions, CRA is a demanding exercise which requires com-
bining scientific knowledge with elaborate literature
review. It involves searching, locating and interpreting rel-
evant information in repositories of scientific peer
reviewed journal articles - a process which can be
extremely time-consuming because the data required for
CRA of just a single carcinogen may be scattered across
thousands of articles. Over the recent years, while the
need for CRA has grown, the task has also turned increas-
ingly complex due to the rapid development of molecular
biology techniques, the increased knowledge of mecha-
nisms involved in cancer development, and the exponen-
tially growing volume of CRA literature (e.g. the
MEDLINE database [19] of biomedical research articles
expanded with over 0.5 M references last year and now
includes over 17 million in total). Under these circum-
stances, CRA is getting too challenging to manage via
manual means.
To gain an understanding of how TM could best assist
CRA, we conducted an initial study where we interviewed
14 experienced risk assessors working for different
national and international CRA authorities in Sweden1
[16]. During this study, the risk assessors described the
following steps of their work: (1) identifying the journal
articles relevant for CRA of the chemical in question, (2)
identifying the scientific evidence in these articles which
help to determine whether/how the chemical causes can-
cer, (3) classifying and analysing the resulting (partly con-
flicting) evidence to build the toxicological profile for the
chemical, and (4) preparing the risk assessment report.
These steps are conducted largely manually, relying on
standard literature search engines (e.g. provided with
PubMed) and word processors as technical support. CRA
of a single chemical may take several years when done on
a part time basis. The risk assessors were unanimous
about the need to increase the productivity of their work
to meet the current CRA demand. They reported that
locating and classifying the scientific evidence in literature
is the most time consuming phase of their work and that
a tool capable of assisting this phase and ensuring that all
the potentially relevant evidence is found would be partic-
ularly helpful.
It became clear to us that a prerequisite for the develop-
ment of such a tool would need to be an extensive speci-
fication of the scientific evidence used for CRA. This
evidence -- which forms the basis of all the subsequent
steps of CRA -- is described in the guideline documents of
major international CRA agencies, e.g. European Chemi-
cals Agency [20] (ECHA), the United States Environmen-
tal Protection Agency [17] (EPA), and the International
Agency for Research on Cancer (IARC) [21]. The guideline
documents describe various human, animal (in vivo), cel-
lular (in vitro) and other mechanistic data which provide
evidence for both hazard identification (i.e. the assess-
ment of whether a chemical is capable of causing cancer)
and the assessment of the Mode of Action (MOA) (i.e. the
sequence of key events that result in cancer formation, e.g.
mutagenesis, increased cell proliferation, and receptor
activation). However, our investigation showed that
although these documents constitute the main reference
material available for CRA, they cover the main types of
evidence only, do not specify the evidence at the level ofBMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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detail required for comprehensive data gathering (e.g. do
not provide complete lists of relevant keywords or terms)
and are not updated regularly to include the latest devel-
opments in biomedical sciences. For example, the most
recent EPA CRA guideline was published in 2005 and the
data requirements have not been updated since then.
The same guidelines emphasise, however, the importance
of investigating all the published scientific data on the
chemical in question which might be of potential rele-
vance for CRA. For example, according to ECHA [20] "fail-
ure to collect all of the available information on a
substance may lead to duplicate work, wasted time,
increased costs and potentially unnecessary animal use"
(page 7). Recent research has revealed that conflicting risk
assessments of the same chemical are surprisingly com-
mon [22,23]. Inadequate or imbalanced data may give
rise to such problems. Extensive data gathering is there-
fore essential not only for the coverage but also for the
accuracy of CRA.
Where the guidelines fail to provide sufficient informa-
tion, risk assessors rely on their experience and expert
knowledge. This is not ideal since chemical carcinogenesis
is such a complex process that even the most experienced
risk assessor is incapable of memorizing the wide range of
relevant evidence without the support of a thorough spec-
ification.
Here we report the work we did on obtaining a more ade-
quate specification of the scientific evidence for CRA. Ide-
ally, a comprehensive knowledge resource is needed
which specifies the range of relevant evidence and pro-
vides extensive lists of keywords to support the gathering
of this evidence in literature. Given the dynamic nature of
CRA data, the best approach long term would be to
develop technology for automatic acquisition and updat-
ing of such a resource from CRA literature [1,2]. However,
the very development of such technology requires target
specification of the scientific evidence more comprehen-
sive than that currently provided. Therefore, in this first
work, we opted for expert annotation of biomedical liter-
ature according to the evidence it offers for CRA.
Following the recommended practices of biomedical cor-
pus design by Cohen et al. [24] as far as practical, we con-
structed a representative, balanced CRA corpus of 1297
MEDLINE abstracts from a set of journals typically used
for CRA. A user-friendly annotation tool was designed
which experts could use to annotate abstracts (i) for the
relevance for CRA and (ii) according to the types of evi-
dence they provide for the task. Three experts (experi-
enced risk assessors) agreed on the annotation guidelines
and produced a corpus which contains 1164 abstracts
judged as relevant and annotated for 1742 unique key-
words (words or phrases) indicating the evidence they
offer for CRA. The experts grouped the keywords accord-
ing to the types of evidence they provide for the task, and
organized them into a taxonomy which contains 48 dis-
tinct classes and covers a variety of data related to carcino-
genic activity, MOA and toxicokinetics. We measure the
inter-annotator agreement of both relevance and keyword
annotation tasks. In addition, we report a series of experi-
ments which involve training and testing automatic clas-
sifiers to assign PubMed abstracts to taxonomy classes.
Finally, a simple user test in a near real-world CRA sce-
nario is reported. The evaluation we report demonstrates
that our taxonomy is highly accurate and can be useful for
practical CRA. The materials we have produced can thus
provide valuable support for manual CRA as well as facil-
itate the development of an approach based on TM. We
discuss refining and extending the taxonomy further via
manual and machine learning approaches, and the subse-
quent steps required to develop TM to support the entire
CRA workflow.
The rest of this paper is organized as follows: The Methods
section introduces the CRA corpus, the annotation tool,
the annotation guidelines, the principles of taxonomy
construction, and the automatic classification methods.
The Results section describes first the annotation work
and the resulting taxonomy. The results of the inter-anno-
tator agreement tests, the automatic classification experi-
ments and the user-test are then reported. The Discussion
and Conclusion section concludes the paper with compar-
ison to related research and directions for future work.
Methods
Cancer Risk Assessment Taxonomy
Three experienced risk assessors helped to construct the
resources described in the following four sections, respec-
tively: (i) a representative corpus of CRA literature for
parts of hazard identification (i.e. the assessment of
whether a chemical is capable of causing cancer), (ii) a
tool for expert annotation of the corpus, (iii) an anno-
tated corpus, and (iv) a taxonomy which classifies and
organizes the scientific evidence discovered in the corpus.
CRA corpus
Most CRA literature is now available electronically via
online resources such as the National Library of Medi-
cine's PubMed system [25] and databases such as the Inte-
grated Risk Information System (IRIS) [26], TOXicology
Data NETwork [27] and the Organisation for Economic
Co-operation and Development (OECD) Global Portal to
Information on Chemical Substances [28]. As PubMed is
by far the most frequently used resource in CRA, we
selected 15 journals available via this system which are
used frequently for CRA and jointly provide a good cover-
age of the main types of scientific evidence relevant for theBMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
Page 4 of 19
(page number not for citation purposes)
task. From these 15 journals (listed in Table 1), all the
abstracts from years 1998 to 2008 which include one of
eight test chemicals were downloaded for further analysis.
The eight chemicals are shown in Table 2. They were
selected by the experts on the basis that they are (i) well-
researched using a range of scientific tests and (ii) repre-
sent the two most common MOAs - genotoxic and non-
genotoxic2. Although full articles are known to provide
richer data for TM purposes than abstracts, [24], we
focussed on abstracts in this work because they are the
typical starting point in CRA. The literature search was
limited to recent 10 years. Since many of the selected
chemicals are well-studied, this yielded a sufficient
number of abstracts for annotation. All the retrieved
abstracts were included, except for benzo(a)pyrene for
which only the latest 200 (out of the c. 900 in total) were
considered. The resulting corpus of 1297 abstracts is dis-
tributed per chemical as shown in Table 3.
Annotation tool
Risk assessors typically (i) read each abstract retrieved by
PubMed to determine its relevance for CRA, and (ii) clas-
sify each relevant abstract based on the types of evidence
it provides for CRA. We designed a tool for expert annota-
tion which imitates this process as closely as possible.
The tool provides two types of functionality. The first ena-
bles the experts to classify abstracts using the classical IR
concept of Document Relevance. The judgements are
made at the document level. An abstract is marked as rel-
evant or irrelevant if the expert deems after reading the
title and the abstract that it is not relevant for CRA. An
abstract can also be marked as unsure. The second func-
tionality enables the experts to annotate such keywords
(words and phrases) in abstracts and their titles which
indicate scientific evidence relevant for examining the car-
cinogenic properties of chemicals. This annotation is
grounded in actual pieces of text. Initially a very shallow
taxonomy (including only general scientific evidence per-
taining to human, animal and cellular data) and two types
of MOA (genotoxic and non-genotoxic) was integrated
inside the tool. As explained below, this was gradually
extended as the annotation progressed further. The tool
permits annotating any number of relevant keywords in
the abstracts, attaching them to any (leaf or internal) node
in the taxonomy, and classifying the same text in more
than one way.
The tool was implemented inside the Mozilla Firefox
browser using its extension facility. The implementation
enables PubMed abstracts to be viewed inside a familiar
web-browsing environment and also to be classified
according to the specialized taxonomy. Previous work has
observed that integrating custom functions within a famil-
iar document browsing environment greatly encourages
user uptake [8]. The CRA analysed abstracts could then be
stored, reviewed by others and edited. In this way, the
deployment of the analysis in a genuine CRA scenario was
able to be quickly tested. A screenshot illustrating the
annotation tool is provided in Figure 1.
Annotation guidelines
The three experts agreed on the guidelines of document
relevance and keyword annotation. The guidelines were
developed so that one of the experts conducted annota-
tion based on the initial set of principles agreed among
the three experts. The other two evaluated the outcome,
the disagreement cases were discussed, and the annota-
tion principles were improved where possible. This proc-
ess (crucial for maintaining quality) was repeated on a
subset of the corpus for several times. The guidelines
described below are the final result of this work.
Relevance annotation
The aim of the relevance annotation is to classify each
abstract in the corpus as relevant, irrelevant or unsure with
regard to hazard identification and MOA assessment.
Since current CRA guidelines do not provide clear advice
for this step, the experts agreed on the annotation princi-
ples based on their experience with CRA literature. They
agreed that the abstracts of articles focussed on initiator/
promoter studies or studies on chemoprevention where
the chemical in question is used as a model compound
should be considered as relevant because they invariably
contain data interesting for CRA. They also agreed that the
abstracts of articles focussed only on exposure assessment
should not be included because they are not suitable for
hazard identification. Any other abstracts should be
examined carefully for their relevance for CRA using
expert judgement.
Table 1: Selected journals
Journal name Number of abstracts
Archives of Toxicology 56
Cancer Letters 80
Cancer Research 75
Carcinogenesis 135
Chemical Research in Toxicology 106
Chemico-Biological Interaction 169
Environmental and Molecular Mutagenesis 45
Environmental Health Perspectives 97
Mutagenesis 31
Mutation research 142
Regulatory Toxicology and Pharmacology 24
Science of the Total Environment 30
Toxicological Sciences 164
Toxicology and Applied Pharmacology 106
Toxicology Letters 110BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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As a general rule, when an abstract contains evidence rel-
evant for CRA, it should be classified as relevant, even
when the name of the chemical of interest is missing in
the abstract or the title. Although some such abstracts may
turn out to be irrelevant after reading the full article,
experts agreed that since they are potentially relevant, they
should be included for further assessment as not to lose
data valuable for CRA. Appendix 1 shows sentences from
some abstracts judged as relevant where the evidence for
relevance is highlighted using bold font.
When the abstract (or its title) either contains no evidence
for relevance or contains "negative" evidence (evidence
which indicates irrelevance), it is classified as irrelevant.
Negative evidence includes, for example, diseases or end-
points unrelated to cancer (e.g. effects on muscle contrac-
tion or loss of hearing). Appendix 2 shows example
sentences from irrelevant abstracts with negative evidence
highlighted.
Not all the abstracts are clearly relevant or irrelevant
according to these criteria. Some abstracts include only
vague evidence for relevance. Some contain conflicting
(both positive and negative) evidence. For example,
effects on cell death (relevant for CRA) may occur in the
same abstract with plants (irrelevant for CRA). Others
include evidence whose association with cancer develop-
ment is currently unclear or evidence which focuses on
studies on single chemicals in complex mixtures such as
tobacco smoke. The experts decided to deal with such
challenging abstracts on case by case basis.
Keyword annotation
The aim of the keyword annotation is to highlight such
keywords (words or phrases) in abstracts which indicate
relevant evidence for hazard identification and MOA
assessment of chemicals. The experts found keyword
annotation easy to understand since they typically look
for words and phrases while reading abstracts, and since
existing CRA guidelines provide some sample keyword
lists to support data gathering. It was agreed that the key-
word annotation should focus on the following main
types of data considered in CRA [17]:
1. Carcinogenic activity. Various types of human, ani-
mal (in vivo), cellular (in vitro) and other mechanistic
data provide evidence for CRA. Risk assessors pay
attention to a variety of keywords indicating different
study types in texts when aiming to locate this data.
For example, the appearance of the keyword haemo-
globin-adduct may indicate that the abstract focuses on
a biomarker study, and the appearance of humans in
the same abstract may suggest that the biomarker
study focuses on humans rather than e.g. animals. It
was agreed that the experts would annotate all the key-
words which jointly identify the types of scientific data
offered by the abstract.
2. Mode of Action (MOA). A MOA is a core concept in
CRA. It specifies the key events leading to cancer,
explaining the genetic and cellular alterations which
result in the appearance of the scientific data men-
tioned above. Different chemicals act according to dif-
Table 2: Selected chemicals
Chemical MOA Occurrence Causes Examples of tumors
1,3-Butadiene Genotoxic Used in production of synthetic 
rubber.
Mutations Leukemia
Benzo(a)pyrene Genotoxic Incomplete burning of coal, oil and 
garbage.
Mutations Skin, lung
Diethylnitrosamine Genotoxic Found in foods, tobacco products 
and industrial solvents.
Mutations Liver
Styrene Genotoxic Used in the manufacture of plastics 
and rubber.
Mutations Lung
Chloroform Non-genotoxic Laboratory solvent and dry cleaning 
agent.
Cell death, regenerative proliferation. 
Hormonal receptor activation.
Liver, kidney
Diethylstilbestrol Non-genotoxic Synthetic estrogen. Vagina, breast
Fumonisin B1 Non-genotoxic A toxin produced by Fusarium 
moulds, found in foods.
Cell death, regenerative proliferation. Oesophageal cancer, liver
Phenobarbital Non-genotoxic Barbiturate used as anticonvulsant. Stimulates proliferation inhibits 
apoptosis.
Liver (in laboratory animals)
Table 3: Number of abstracts per chemical
Chemical name Number of abstracts
1,3-Butadiene 195
Benzo(a)pyrene 200
Chloroform 96
Diethylnitrosamine 221
Diethylstilbestrol 145
Fumonisin B1 80
Phenobarbital 270
Styrene 162BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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ferent MOAs, and risk assessors search evidence for a
specific MOA type in abstracts. Two main types of
MOA can be distinguished: genotoxic and non-geno-
toxic (both can be further divided into various sub-
types). Chemicals acting by a genotoxic MOA interact
with DNA, while chemicals acting by a non-genotoxic
MOA induce cancer without interfering directly with
DNA. To identify the MOA type in question, risk asses-
sors examine scientific data (e.g. haemoglobin-adduct
data) in conjunction with mutations in genes. A
number of genes (e.g. oncogenes and tumor suppres-
sor genes) are known to be involved in cancer devel-
opment and are therefore used as evidence. Some of
these are shown in Table 4, together with proteins reg-
ulated by them. For example, an abstract which
reports mutation in p53 gene resulting in decreased
expression of its downstream protein p21 suggests
genotoxic MOA while an abstract which describes acti-
vation of FasL resulting in Caspase-8 mediated apop-
tosis suggests non-genotoxic MOA.
3. Toxicokinetics. Toxicokinetics describes the process
of uptake of chemicals by the body: the metabolism
and biotransformation, and the distribution and
excretion. Accurate MOA classification of some chem-
icals requires evidence for a certain type of toxicokinet-
ics. For example, aflatoxinB1 needs to be activated by
CYP 450 to be able to bind to DNA.
Many abstracts focus on several chemicals and/or refer to
results conducted in previously published experiments. It
was agreed that the experts would focus only on the chem-
ical of interest and on new rather than previously pub-
lished results. For maximum accuracy, the experts were
not required to annotate every potentially relevant key-
word but only the ones which they perceived as the most
important or dominant. Where the same keyword
appeared several times in the abstract or appeared in dif-
ferent forms (e.g. tumors, tumor) it was annotated at least
once.
Principles of taxonomy creation
The keyword annotation resulted in lists of words and
phrases indicating evidence for CRA. The next task was to
classify this evidence and organize it into a taxonomy. We
Annotation tool: This figure displays the annotation tool Figure 1
Annotation tool: This figure displays the annotation tool.
Table 4: Examples of cancer related genes and proteins 
regulated by these genes
Genes Regulated proteins
p53 Noxa, Puma, p21, Mdm2
PTEN PIP3, Akt, Cyclin D1
Ras Raf1, Mek, Erk, Akt
FasL Caspase-8, Caspase-3, Bid
RB E2F, Cyclin E, Cyclin ABMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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mentioned earlier that initially only a very shallow taxon-
omy was implemented inside the annotation tool. As the
keyword annotation progressed, this taxonomy was grad-
ually extended and refined further with novel classes and
class members. The resulting taxonomy relies solely on
expert knowledge. Experts were merely advised on the
main principles of taxonomy creation: the classes should
be conceptually coherent and their hierarchical organiza-
tion should be in terms of coherent sub- and superordi-
nate relations.
Automatic Classification
To find out whether the classification created by experts
provides a good representation of the corpus data and is
machine learnable, we conducted a series of abstract clas-
sification experiments. A number of standard feature
extraction, feature selection and machine learning meth-
ods were used and compared in these first experiments to
identify optimal methodology for our data and task.
These are introduced in the subsequent sections.
Feature extraction
The first step of our text categorization (TC) approach is to
transform documents into a feature vector representation.
We experimented with two document representation
techniques. The first one is the simple 'bag of words'
approach (BOW) which considers each word in the
abstract as a separate feature. BOW was evaluated using
three methods which have proved useful in previous TC
work: (i) stemming (using the Porter stemmer [29])
which removes affixes from words, (ii) the TFIDF weight-
ing [30], and (iii) stop word removal (which removes the
uninformative words, e.g. articles and prepositions).
The second technique is the recent 'bag of substrings'
(BOS) method by [31] which considers the whole abstract
as a string and which extracts from it all the length p sub-
strings without affix removal. BOS has proved promising
in recent biomedical TC experiments [31,32] and unlike a
traditional grammatical stemmer, it does not require
domain tuning for optimal performance. Because it gener-
ates substrings with a fixed length p, a word shorter than p
- 2 can get obscured by its context3. For example, 'mice'
could be transformed to ' _mice_a', '_mice_b',..., which is
less informative than the original word form. Therefore,
we enriched the BOS features with word forms shorter
than p - 2.
Feature selection
We employed two feature selection methods for dimen-
sionality reduction. The first is Information Gain (IG)
which has proved useful in TC [33]. Given a feature's dis-
tribution X and class label distribution Y, IG(X) = H(Y) -
H(Y | X), H(X) is the entropy of X. The second method
fscore optimises the number of features (N). Features are
first ranked using the simple fscore criterion [34], and N is
selected based on the performance of the SVM classifier
using the N features.
Classification
We experimented with three well-known classifiers: Naive
Multinomial Bayesian (NMB), Complement Naive Baye-
sian (CNB) [35] and Linear Support Vector Machines (L-
SVM) [36].
NMB  is a simple, widely used classifier in TC [30]. It
selects the class C with the maximum probability given
the document d: argmaxc Pr(C) Πw∈ d Pr(X = w|C). Pr(C)
can be estimated from the frequency of documents in C.
Pr(X = w|C) is estimated as the fraction of tokens in docu-
ments of class C that contain w.
CNB extends NMB by addressing the problems it has e.g.
with imbalanced data and the weight magnitude error.
The class c  of a document is:
.   is the number
of times term i occurs in classes other than c. α and αi are
the smoothing parameters. p(θc) is the prior distribution
of class c.
We used WEKA software environment [37] for the imple-
mentation of NMB and CNB.
SVMs have been reported to outperform other TC meth-
ods on many TM tasks and have the benefit that they work
well even when the data is sparse. L-SVM is the basic type
of SVM which produces a hyperplane that separates two-
class samples with the maximum margin. The method
handles high dimensional data efficiently, and has been
shown to perform well in TC [38]. Given the data set X =
(x1, y1),...,(xn, yn) yi ∈ {-1, +1}, L-SVM requires a solution
w to the following unconstrained optimisation problem:
. Cost parame-
ter C was estimated within range 22,...,25 on training data
using cross validation. The C  of the positive class was
weighted by class population ratio  .
The feature vector was normalized before inputting into L-
SVM, because the scaling is important for SVM [39]. LIB-
LINEAR [40] was used for the implementation of L-SVM.
Results
The following sections report our results first for the anno-
tation and taxonomy construction tasks, then for the
automatic classification experiments, and finally for the
user test which involves applying the automatic classifica-
argmax logp f log cc i i
Nci i
Nc
[( ) ] q
a
a −
+
+ ∑

 Nci 
min C y
T
i i
n
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2 10
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tion technology to corpus data of unseen chemicals and
evaluating the resulting classified data using expert judg-
ment.
Annotation tasks
Using the annotation tool and the guidelines we have
described, the experts annotated each of the 1297
abstracts for (i) relevance and (ii) keywords. They classi-
fied 89.4% of the abstracts as relevant, 10.1% as irrelevant
and 0.5% as unsure. The small proportion of unsure
abstracts can be explained by the general CRA principle
which the risk assessors followed which encourages them
to collect all the data of potential relevance for further
assessment [17,20].
We used the widely employed Kappa statistics [41] to
measure the level of inter-annotator agreement in rele-
vance classification. Although not a fully ideal measure
(see e.g. [42] for a discussion and criticism), we adopted it
for this first annotation effort due to its familiarity. We
used the Cohen's chance agreement model [41] since
Eugenio and Glass [43] have shown that the model is bet-
ter than Siegel and Castellan's model [44] in the studies
such as ours where the distribution of categories is not
equal between the annotators.
The Kappa statistics was calculated on data which two
experts annotated independently4. 26 abstracts per chem-
ical were selected randomly from the 15 and 16 journals
listed in Table 1 and Appendix 3, respectively. The 16
journals in Appendix 3 were selected on the basis of their
likely irrelevance for CRA. They were included to make the
annotation task harder, given the high proportion of rele-
vant abstracts among the 15 journals used for corpus cre-
ation. The resulting test data contains 208 abstracts in
total. The test set was kept intentionally small to facilitate
thorough error analysis. Table 5 shows basic statistics with
regard to the experiment: the values that the Kappa func-
tion requires as input. The Kappa statistics K is calculated
as follows:
pa  measures the observed level of agreement while pe
measures the chance agreement between two annotators.
The maximum value of Kappa score occurs when the
agreement is one (pa = 1). The minimum value 0 indicates
that the agreement is by chance (pa = pe). Our Kappa result
is 0.68. According to the scale of [45], this value indicates
substantial agreement between the annotators.
The annotators disagreed on 24 (11.5%) of the abstracts.
Half of the disagreements (12) were due to one of the
annotators failing to notice keywords in text, and thus
erroneously judging abstracts as irrelevant. These disa-
greements do not warrant improving the annotation
guidelines but are likely to decrease when the annotators
gain more experience. The other half of the disagreements
(12) were caused by one (or both) of the following prob-
lems:
• Environmental studies can provide important evi-
dence for CRA, but it is unclear what kind of environ-
mental studies should be included in CRA (e.g.
measurements of exposure levels in specific cities,
areas, or ethnic/occupational groups).
￿ Conflicting information in abstracts: the abstracts
can include both relevant and irrelevant information,
making it difficult for the annotators to decide on the
relevance.
The keyword annotation was done for the 1164 abstracts
deemed relevant during the relevance annotation. Key-
words mentioned in existing CRA guideline documents
were identified along with many novel ones missing in
them (these are illustrated together with the taxonomy in
the following section). A total of 1742 unique keywords
were identified. Figure 2 shows an example of an anno-
tated abstract where keywords indicating different types of
evidence are highlighted in blue, red, and green fonts.
Since the experts were not required to annotate every sin-
gle relevant keyword, calculating inter-annotator agree-
ment was not meaningful. However, we evaluated the
keyword annotation as part of the taxonomy classification
and provide the corresponding inter-annotator agreement
scores in the following section.
K
pa pe
pe
pp p
pp pp p
a
e
=
−
−
=+
=+
1
11 22
11 22 .. ..
(1)
Table 5: Statistics used in the inter-annotator agreement test
Annotator 2 rel Annotator 2 irr Annotator 1 total
Annotator 1 rel 145(p11= 0.697) 16(p12 = 0.077) 161(p1· = 0.774)
Annotator 1 irr 8 (p21= 0.038) 39(p22 = 0.186) 47 (p2· = 0.226)
Annotator 2 total 153(p·1 = 0.736) 55(p·2 = 0.264) 208(1)BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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Taxonomy
The keyword annotation of the first two chemicals (one
genotoxic and one non-genotoxic) resulted in several
updates in the classification and considerable extension of
the initial taxonomy implemented inside the annotation
tool. During the annotation of the subsequent six chemi-
cals, only minor changes were required: some classes were
combined, divided or refined following the discussion
among the experts. The resulting taxonomy consists of
three sub-taxonomies, corresponding to 1) carcinogenic
activity, 2) MOA and 3) toxicokinetics.
Carcinogenic activity
The first sub-taxonomy, shown in Figure 3, specifies the
types of data which provide evidence for carcinogenic
activity. Five main classes are included: "human study/
epidemiology", "animal study", "cell experiments",
"study on micro-organisms", and "subcellular systems".
The first three of these divide further into subclasses. For
example, "human study/epidemiology" has several sub-
classes corresponding to different types of human studies:
"polymorphism", "biomarkers", "tumor related effects",
"morphological effects on tissues and organs", and "bio-
chemical and cellbiological effects". Each class is illus-
trated in the figure by 2-3 example studies, corresponding
to individual keywords in the annotated abstracts (e.g. cell
cycle arrest, gene expression and protein kinase C for "bio-
chemical and cellbiological effects"). Most child nodes in
this sub-taxonomy have a type of relation with their par-
ent class. For example, "polymorphism" is here a type of
"human study". The only exceptions are "study length"
and "the type of animals" under "animal studies" class.
They provide additional information about animal stud-
ies important for CRA.
Mode of Action
The second sub-taxonomy focuses on MOA and specifies
the types of scientific evidence required for MOA classifi-
cation. Shown in Figure 4, this sub-taxonomy currently
covers the two most frequent MOA types. In this taxon-
omy, the sub-classes of "genotoxic" and "non-genotoxic"
specify different types of evidence for the MOA type in
question. For example, "strand breaks", "adducts", "chro-
mosomal changes" ("micronucleus" and "chromosomal
aberrations"), "mutations" and "other DNA modifica-
tions" each provide different types of evidence for the gen-
otoxic MOA.
Annotated abstract: Figure displaying the annotated abstract Figure 2
Annotated abstract: Figure displaying the annotated abstract.BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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Toxicokinetics
The third sub-taxonomy focuses on toxicokinetics, shown
in Figure 5, specifying the different parts of this process. It
consists of four main classes: "absorption, uptake, distri-
bution, excretion", "bioaccumulation/lipophility",
"metabolism", and "toxicokinetic modelling". For exam-
ple, the class "metabolism" gives information about the
distribution of the chemical in the body, e.g. "biodegrada-
tion", "metabolic enzymes", "biotransformation".
The resulting taxonomy, consisting of the three sub-taxon-
omies, includes 48 classes in total. Table 6 shows the total
number of abstracts and annotated keywords belonging
to each class. It shows that 82.4% of the annotated
abstracts include keywords belonging to the "carcinogenic
activity" sub-taxonomy, and 50.3% and 28.1% belonging
to the "MOA" and "toxicokinetics" sub-taxonomies,
respectively. As we go into the deeper levels of the taxon-
omy, the number of abstracts associated with individual
classes gets increasingly small.
We conducted an inter-annotator agreement test to meas-
ure the agreement with which the experts assigned
abstracts to classes via keyword annotation. For each of
the eight chemicals (see Table 2), 10 abstracts from 15
journals listed in Table 1 were randomly retrieved from
PubMed by using the chemical name as the search term.
Two experts performed both relevance and keyword
annotation using the final taxonomy in the annotation
tool, and we investigated the agreement with which they
associated the same abstracts with the same classes. We
used the Kappa measure introduced earlier in section
2.3.1.
Because the classes are hierarchically organized, disagree-
ment on a child class may still mean agreement on the
parent class. For example, annotator 1 (A1) may select
"type of animal" while annotator 2 (A2) may select "ani-
mal study". Although these classes are not identical they
are related as "animal study" is the parent class of "type of
animal", and therefore there is an implicit agreement on
the class "animal study". We calculated the agreement
based on both explicit agreement and implicit (parent)
agreement. However, the same parent agreement was
counted only once for each abstract. For example, if A1
selected "animal study" and A2 "type of animal" and
"study length", the two implicit parent agreements on
"animal study" were counted as one agreement only.
Table 7 shows the number of annotated unique keywords
along with the agreement statistics. We can see that one
annotator (A1) produced significantly more annotations
Taxonomy for carcinogenic activity: A flow chart displaying taxonomy for carcinogenic activity Figure 3
Taxonomy for carcinogenic activity: A flow chart displaying taxonomy for carcinogenic activity.BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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than the other one (A2): 78 in total. This applies to the
"carcinogenic activity" sub-taxonomy and in particular to
"toxicokinetics" for which A1 produced 1.67 times more
annotations than A2. With the MOA taxonomy an oppo-
site trend can be seen: A2's proportion is significantly big-
ger than that of A1.
The average agreement between the annotators is the
highest with "carcinogenic activity" and "MOA" at 78%.
With "toxicokinetics" it is significantly lower (62%). The
overall agreement is 76%. These results are good, particu-
larly considering that the annotation was done using a rel-
atively high number of classes and the chance agreement
is low at 1.5%.
We conducted error analysis of the annotations the anno-
tators disagreed on. The main source of disagreement was
the different annotation style of the two annotators. A1
annotated as many words as possible, aiming for a maxi-
mum number of taxonomy classes per abstract. A2 anno-
tated just one or a few words that classify the abstract as
precisely as possible. In other words, A1 focussed on
word-level annotation while A2 focussed on document
level annotation (even when annotating keywords). Both
approaches are plausible (given the annotation guide-
lines) and both resulted in annotations useful for CRA.
The error analysis revealed that some classes are not spe-
cific enough to yield unique distinctions and as a conse-
quence, some keywords are even assigned to different sub-
taxonomies. For example, A1 typically assigned protein
changes to "biochemical effects" in the "carcinogenic
activity" sub-taxonomy, while A2 assigned them to e.g.
"post-translational modifications" in the "MOA" sub-tax-
onomy. Both annotations are plausible given the current
model, but future work should focus on refining the tax-
onomy further to obtain clearer distinctions.
Automatic classification
We evaluated the automatic classification against the
expert annotated CRA corpus. We used the standard eval-
Taxonomy for mode of action: A flow chart displaying taxonomy for mode of action Figure 4
Taxonomy for mode of action: A flow chart displaying taxonomy for mode of action.
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uation measures of recall (R), precision (P) and F measure
(F) to evaluate the rate with which the classification
assigned abstracts to the correct taxonomy classes. These
measures are defined as follows:
where P+/N: positive/negative population; TP: true posi-
tive; FN: false negative, and FP: false positive. Our random
baseline is  .
Document preprocessing
We first evaluated the BOW preprocessing technique with
and without the use of (i) the Porter stemmer [29], (ii)
TFIDF, (iii) stop word removal, and (iv) their combina-
tions. The evaluation was done in the context of binary
relevance classification of abstracts (not in the context of
the main taxonomic classification task to avoid overfitting
preprocessing techniques to the taxonomy). Only (iii)
improved the performance of all the classifiers (data not
shown here) and was thus adopted for the main experi-
ments. The poor performance of (i) demonstrates that a
standard stemmer is not optimal for biomedical data. As
highlighted by Han et al. and Wang et al. [31,32], seman-
tically related biological terms sharing the same stem are
not always reducible to the stem form.
Feature selection
We evaluated the feature selection methods with two tax-
onomy classes: the most balanced class 'animal study'
(positive/negative 1:1.4) and an imbalanced class
'adducts' (positive/negative 1:6.5). IG was used for the
fixed N setting and fscore for the dynamic N setting. Each
combination of classifiers (NMB/CNB/SVM), document
representations (BOW, BOS) and settings for N
(dynamic,...,83098) was evaluated. The results showed
that the dynamic setting yields consistent improvement for
all the setups (although the impact on SVM's is not big)
and that the optimal N varies by the data and the classifier
(the data not shown). Thus, we used the dynamic feature
selection in the taxonomic classification.
Taxonomic classification
We ran two sets of experiments on the corpus, using 1)
BOW and 2) BOS for feature extraction. Without feature
R
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The toxicokinetics taxonomy: A flow chart displaying the toxicokinetics taxonomy Figure 5
The toxicokinetics taxonomy: A flow chart displaying the toxicokinetics taxonomy.
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selection, BOW had c. 9000 features and BOS c. 83000.
Features were selected using fscore. For each class with
more than 20 abstracts (37 in total)5, three "one against
other" classifiers (NMB, CNB and L-SVM) were trained
and tested using a standard 10-fold cross validation.
Table 8 shows the average performance across the whole
taxonomy. The performance of BOS is better than that of
BOW according to all the three measures. On average,
BOS outperforms BOW by 4% in P and F, and 3% in R.
SVM yields the best overall P and F (0.71 and 0.74) with
Table 6: Number of abstracts, keywords and FScore per class
Class Abstracts Keywords F-Measure
Carcinogenic activity 1023 1157 92.8
Human study/epidemiology 190 (171) 44 77.7
Tumor related 39 28 56.3
Morphological effect on tissue/organ 2 1
Biochemical/cellbiological effects 2 3
Biomarkers 35 14 68.4
Polymorphism 37 32 79.5
Animal study 629 (546) 46 80.2
Study length 156 (3) 3
2-year cancer bioassay 14 9
Short and medium 143 110 45.9
Tumors 186 73 74.3
Preneoplastic lesions 150 121 81.2
Morphological effect on tissue/organ 60 50 46.3
Biochemical/cellbiological effects 135 198 52.1
Biomarker 63
Type of animal 452 (388) 166 70.5
Genetically modified animals 73 76 73.5
Cell experiments 319 (313) 28 78.5
Biochemical/cellbiological effects 100 128 58.7
Subcellular systems 22
Study on microorganisms 44 22 85.2
Mode of Action 653 316 85.5
Genotoxic 426 (72) 16 89.1
Strand breaks 32 12 77.4
Adducts 174 11 89.8
Chromosomal change 84 (36) 23 68.2
Micronucleus 47 5 85.9
Chromosomal aberration 35 10 68.2
Mutations 145 38 85.4
Other dna mods 100 52 62.0
Non-genotoxic 324 (8) 4 76.3
Reactive oxygen species 54 26 70.5
Cytoxicity 50 7 62.0
DNA repair 29 8 64.2
Hormonal receptor 47 30 61.6
Effects on cell proliferation 113 30 69.6
Effects on cell death 110 10 83.3
Transcriptional, translational, posttranslational modifications 27 22 61.2
Peroxisome proliferation 3 2
Inflammation 15 10
Toxicokinetics 365 269 77.7
Absorption, uptake, distribution, excretion 117 45 69.8
Bioaccumulation/Lipophility 0 0
Metabolism 275 (152) 36 76.4
Activation or deactivation 191 161 74.8
Reactive oxygen species 7 6
Toxicokinetic modeling 31 21 84.6
The first column shows the name of a class in the taxonomy. The second column shows the total number abstracts classified in the class (or its sub-
classes). The value in brackets is the number of abstracts classified in the class without taking the sub-classes into account. The third column shows 
the total number of unique keyword annotations for each class. The count does not include the annotations for sub-classes, except for the three 
top level classes where the number of all keywords (also those of sub-classes) are included.BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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BOS. Surprisingly, NMB outperforms CNB with all the set-
tings. NMB yields the best overall R with BOS (0.82) but
its P is notably lower than that of SVM.
Table 9 shows the average P, R and F for the three sub-tax-
onomies using the best performing feature set BOS with
the three classifiers. "Carcinogenic activity" (CA) has the
best F (0.93). Its positive population is the highest (posi-
tive/negative: 5:1). "Toxicokinetics" (TOX) with a lower
positive population (1:2.6) has still good F (0.78). In
these results, R and P are balanced with an average differ-
ence of 0.06.
Table 10 shows the distribution of F across the taxonomy
for different frequency ranges. There is a clear correlation
between frequency and performance: the average F
decreases with descending frequency range, revealing
increased classification difficulty. Classes with more than
300 abstracts have the highest average F (0.80 with stand-
ard deviation (SD) 0.08). Classes with 20-100 abstracts
have the average F 0.68 (SD 0.11), which is lower but still
fairly good. No class has F lower than 0.46, which is much
higher than the average random baseline of 0.11.
In sum, these experiments demonstrate that the taxonomy
we have created is machine learnable with high accuracy
for the classes for which sufficient corpus data is available.
User Test
A small user test was finally carried out to investigate the
practical usefulness of the automatic classification in a
near real-world CRA scenario. In this test, the best classi-
fier (L-SVM+BOS) trained on the CRA corpus (as
explained in the above section) was applied to the
PubMed abstract data of five unseen chemicals which rep-
resent the same genotoxic (geno) and non-genotoxic
(non) MOAs (see Table 11). The abstracts were down-
loaded from the set of 15 journals listed in Table 1. As
with the CRA corpus, only abstracts from years 1998-2008
were included.
The results were displayed to one of our experts in a web
interface. The expert was invited to imagine that she had
submitted a query to a TM system, the system had classi-
fied each abstract of each chemical to relevant taxonomy
class(es), and the task is to judge whether the proposed
classification is correct. The top 500 BOS features per class
were shown to the expert to aid the judgement.
The results were evaluated using precision (P) (recall
could not be calculated as not all of the positive polula-
tion was known). Table 11 shows the average P per each
(i) chemical and (ii) sub-taxonomy. The results are
impressive: the only chemical with P lower than 0.90 is
polychlorinated biphenyls (PCB). As PCB has a well-
known neuro-behavioural effect, the data includes many
abstracts irrelevant for CRA. The good performance can be
observed across the whole taxonomy: TOX has the best P
(0.99), and CA and MOA have 0.94 and 0.95 P, respec-
Table 7: The distribution of the annotations and the statistics of agreement
A1 A2 Agreement Disagreement
Carcinogenic activity 281 (0.55) 217 (0.50) 194 (0.78) 55 (0.22)
Mode of Action 158 (0.31) 172 (0.40) 129 (0.78) 36 (0.22)
Toxicokinetics 75 (0.15) 45 (0.10) 37 (0.62) 23 (0.38)
Irrelevant 0 2 0 2
Total 514 436 360 (0.76) 116 (0.24)
The columns A1 and A2 correspond to the annotators 1 and 2, respectively. The values shown are the number of annotations by the annotator. 
The last two columns show the statistics of agreement and disagreement. Rows 2-4 show the results for the three sub-taxonomies and the last row 
indicates the number of irrelevant abstracts among the relevant ones.
Table 8: Performance of classifiers with BOS and BOW
Method Feature Set P R F
NMB BOW 0.59 0.75 0.66
NMB BOS 0.62 0.82 0.70
CNB BOW 0.52 0.74 0.60
CNB BOS 0.57 0.76 0.64
SVM BOW 0.68 0.76 0.71
SVM BOS 0.71 0.77 0.74
Table 9: Results for the three sub-taxonomies
Class Method P R F
CA NMB 0.94 0.89 0.91
CA CNB 0.92 0.94 0.93
CA SVM 0.93 0.93 0.93
MOA NMB 0.88 0.81 0.84
MOA CNB 0.84 0.82 0.83
MOA SVM 0.92 0.80 0.86
TOX NMB 0.66 0.83 0.74
TOX CNB 0.70 0.80 0.75
TOX SVM 0.76 0.79 0.78BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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tively. Most errors are due to the lack of training data for
low frequency classes. For example, the CRA corpus has
only 27 abstracts in "DNA repair (damage)" class, while
the data for new chemicals have many.
The expert found this evaluation easy to conduct. She felt
that if such an automatic classification system was availa-
ble to support real-world CRA, it could significantly
increase the productivity and also lead to more consistent
and thorough CRA since manual gathering of such a wide
range of scientific evidence from abstracts is very difficult.
This result is encouraging. Larger tests using several
experts are required to investigate the full performance of
automatic classification on unseen corpus data. We plan
to conduct such tests after we have extended the initial tax-
onomy further to cover additional, finer-grained MOA
types (as described in the following section).
Discussion and Conclusion
The results of our inter-annotator agreement tests, auto-
matic classification experiments and the user test all dem-
onstrate that the taxonomy created by risk assessors is
accurate, well-defined, and can be useful in practice. This
is particularly encouraging considering that the taxonomy
is based on expert annotation of biomedical texts.
The annotation of biomedical corpora is a challenging
task [24]. It is also an important task since most current
TM approaches rely on annotated corpora and are there-
fore dependent on the quality of these resources. Various
annotation schemes have been proposed which involve
either linguistic or expert annotation. As highlighted by
Kim et al [46], expert annotation is more challenging and
more prone to inter-annotator disagreement than better-
constrained linguistic annotation. We believe that we
obtained promising results regardless of this because our
interdisciplinary team included also risk assessors: we
developed an annotation approach which imitates their
current practices as closely as possible and involves gath-
ering information specifically for their needs. Like the
recent user-centered annotation scheme of Wilbur et al.
[6] it can support the classification of biomedical litera-
ture along various qualitative dimensions. However, with
the focus on CRA, our scheme is specifically aimed at clas-
sifying cancer related evidence. The latter can be useful for
risk assessment and for e.g. researchers working on cancer
research. A number of works have been reported on dis-
ease- and drug-related TM which have involved similar
knowledge acquisition and classification efforts as our
work, e.g. [47-49] among others. Although some prior
work has been done on cancer-related TM, the work con-
ducted so far has focussed on tasks such as building can-
cer-related databases (e.g. a cancer methylation database
[50]), detecting associations between cancer and specific
genes or proteins [51], classifying abstracts based on the
type of cancer they focus on (e.g. the breast vs. lung can-
cer) [52], and mining clinical records for cancer diagnosis
[53]. No prior work has been done (to the best of our
knowledge) on specifying such a wide range of cancer-
related evidence or developing TM for risk assessment of
potentially carcinogenic substances.
The work we have presented in this paper constitutes the
first step towards developing TM for CRA. The taxonomy
we have constructed provides the practical means to iden-
tify key evidence in CRA literature and to classify this evi-
dence in semantically meaningful classes. The ability to
assign journals, abstracts, and experimental results in the
taxonomy can help risk assessors to (i) keep track of the
evidence covered/not covered and (ii) detect important
statistical tendencies in the CRA literature, e.g. that most
of the scientific data provides evidence for some specific
MOA type.
In the future, we plan to develop and extend the taxon-
omy further. Although our results show that the current
taxonomy provides a good basis for the classification of
CRA literature, it is not comprehensive: more data is
required especially for low frequency classes, and the tax-
onomy needs to be adapted and extended to cover more
specific MOA types (e.g. further subtypes of non-genoto-
xic chemicals) and novel findings.
The taxonomy can be extended using manual annotation,
by supplementing it with additional information in
knowledge resources and/or using automatic methods. A
number of extensive knowledge resources have been built
for biomedicine which also enable classifying concepts in
biomedical texts in semantically coherent classes. The
most prominent of these are widely used to support bio-
medical text mining tasks, e.g. the Medical Subject Head-
Table 10: Mean F and random baseline for taxonomic classes in 
three frequency ranges
No. of abstracts(f) Classes F Random
f > 300 9 0.80 0.38
100 <f ≤ 300 12 0.73 0.13
20 <f ≤ 100 16 0.68 0.04
Table 11: Unseen chemicals and the results of the user test
Name MOA Σ PC l a s s P
Aflatoxin B1 geno 189 0.95 CA 0.94
Benzene geno 461 0.99 MOA 0.95
PCB non 761 0.89 TOX 0.99
Tamoxifen non 382 0.96
TCDD non 641 0.96BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
Page 16 of 19
(page number not for citation purposes)
ings (MESH) ontology [54] and the Unified Medical
Language System (UMLS) knowledge sources (Metathe-
saurus, the Semantic Network, and the Specialist Lexicon)
[55]. Although these general resources lack a number of
concepts important for CRA (e.g. MOA), cover a large
number of concepts irrelevant for CRA, and organize
many similar concepts differently (e.g. do not organize
scientific studies according to their length), some infor-
mation provided in them could further support CRA and
would therefore be worth exploring.
We performed a small experiment to investigate the use-
fulness of MeSH for supplementing our current classifica-
tion. MeSH terms were first retrieved for each abstract
using EFetch [56] and then appended to the BOS feature
vector. The best features were selected using fscore and
classified using L-SVM. The figures included in Table 12
show that the classification improved significantly for
43% of the classes, the majority of which are low in fre-
quency. Although this demonstrates the potential useful-
ness of additional manually built resources, given the
rapidly evolving nature of CRA data, the best approach
long term is to develop technology for automatic updat-
ing of the taxonomy from literature. Given the basic
resources we have constructed and presented in this
paper, the development of such technology is now realis-
tic and can be done using unsupervised or semi-super-
vised machine learning techniques, e.g. [1,57].
Our simple automatic classification method could be
improved in various ways. An obvious way to improve it
is to extend the shallow feature set with more sophisti-
cated features extracted using NLP tools that have been
tuned for biomedical texts, such as taggers and parsers,
e.g. [58], named entity recognizers, e.g. [59], and exploit-
ing lexical resources such as the BioLexion [60].
Given the basic resources described in this paper and the
proposed extensions, our long term goal is to develop a
TM tool to support the entire CRA workflow. Our initial
study (the interviews conducted with risk assessors, see
the Introduction section) revealed that a tool capable of
identifying, ranking and classifying articles based on the
evidence they contain, displaying the results to experts,
and assisting also in the subsequent steps of CRA would
be welcome. Such a tool could significantly increase the
productivity and consistency of CRA and enable risk asses-
sors to concentrate on what they are best at: the expert
judgement. It could also, as a side-effect, keep track of the
CRA process, providing the practical means to address one
of the biggest current problems in CRA: the need for
improved consistency and transparency of risk assess-
ments [23].
Such a tool should be developed in close collaboration
with risk assessors. The interface should be easy to use,
interactive, support search in a graphical manner, include
a helpful statistical summariser, and enable the storage of
interesting results in specific collections. It should provide
online access to CRA guidelines and resources, and be suf-
ficiently flexible to permit specific searchers in selected
repositories of literature. Ideally, it should be designed in
a way that it facilitates also the subsequent steps of CRA,
e.g. the analysis of the retrieved data, the discussion
among the CRA team and the subsequent generation of
the CRA report.
A number of tools have recently been built to assist other
critical activities in biomedicine (e.g. literature curation
for genetics, literature search in plant related literature)
[10-13]. A few of them have also been evaluated for their
practical usefulness in a real-world scenario [8,9]. Such
tools and evaluations act as an important proof of concept
for biomedical TM as well as enable improving existing
technology according to the needs of practical applica-
tions.
Appendix
Appendix 1 Sentences from abstracts relevant for CRA
Keywords representing evidence for relevance are indi-
cated in bold font
Although A:T to T:A transversions  were the major
form of mutation observed following treatment with
each of the three stereoisomers (35-40%), S, S-DEB
induced higher numbers of G:C to A:T transitions,
whereas R, R-DEB treatment resulted in a greater fre-
quency of G:C to T:A transversions.
Measurements of Hprt mutant frequencies (via the T
cell cloning assay) showed that repeated exposures to
Table 12: F gain(ΔF) of MeSH compared to BOS
Distribution of abstracts per class freq. range
Change in F Σ Classes 20-100 100 - 200 200 - 1100
ΔF > 1% 16 (43%) 75% 33% 8%
|ΔF| ≤ 1% 15 (41%) 6% 44% 75%
ΔF < -1% 6 (16%) 19% 33% 17%BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
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18 and 36 ppm BD-diol were significantly mutagenic
in mice and rats.
All three BD exposure indices were associated posi-
tively with leukemia.
Assays for the N, N-(2,3-dihydroxy-1,4-butadyl)
valine (pyr-Val) hemoglobin (Hb) adduct, which is
specific for the highly genotoxic 1,2,3,4-diepoxybu-
tane (DEB) metabolite of BD, have been conducted on
blood samples from all participants in this second
Czech study.
Thus, in terms of mutagenic efficiency, stereochemical
configurations of EB and DEB are not likely to play a
significant role in the mutagenicity and carcinogenic-
ity of BD.
Thus, in mouse liver, the trihalomethanes adminis-
tered by gavage enhanced cell proliferation and
decreased the methylation of the c-myc gene, consist-
ent with their carcinogenic activity.
The data support the hypothesis that PB promotes
neoplastic development through a reduction in the
incidence of cell death.
Appendix 2 Example sentences containing evidence for 
irrelevance
Example sentences containing information (indicated in
bold font) which suggests that the abstract is irrelevant for
CRA
Exposure to 600 ppm styrene caused a 3 dB hearing
loss only at the highest test frequency (8 kHz).
Asthma symptom severity was regressed on pollutants
using generalized estimating equations, and peak
expiratory flow (PEF) was regressed on pollutants
using mixed models.
Collectively, our results indicated that chloroform
directly and concentration-dependently provoked
muscle contraction in swine tracheal smooth mus-
cle.
These results demonstrate that BaP/DMBA causes a
loss of bone mass and bone strength, possibly
through an increase in bone turnover.
Appendix 3 The 16 additional journals used for inter-
annotator agreement test
Journals
Journal of Biological Chemistry
PNAS (Proc Natl Acad Sci)
Pancreas
Bone
Endocrinology
Regulatory Toxicology and Pharmacology
Epidemiology
Blood
Toxicologic Pathology
International Journal of Toxicology
Risk Analysis
Cell Death and Differentiation
American Journal of Epidemiology
American Journal of Industrial Medicine
Toxicology
European Journal of Pharmacology
Appendix 4 Footnotes
1. Institute of Environmental Medicine at Karolinska
Institutet, Swedish Chemical Inspectorate, Scientific Com-
mittee on Occupational Exposure Limits (EU), Swedish
Criteria Group.
2. Chemicals acting by a genotoxic MOA interact with
DNA, while chemicals acting by a non-genotoxic MOA
induce cancer without interfering directly with DNA.
3. Minus 2 because of space characters.
4. Since our third expert was not available during the
inter-annotator agreement tests, the tests were conducted
using two experts only.
5. The classes with less than 20 abstracts may have less
than 2 positive abstracts in each fold of 10 fold CV, which
is not representative of the class population.
Authors' contributions
All four authors participated equally in the work reported
in this paper. AK wrote most of the paper and together
with US designed, supervised and coordinated the project.
IS conducted the annotation work, designed the taxono-BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
Page 18 of 19
(page number not for citation purposes)
mies, and conducted the inter-annotator agreement tests
and the user test with the assistance of US. LS developed
the annotation tool, constructed the CRA corpus, imple-
mented the automatic classification approach and per-
formed the evaluation of these resources with the
assistance of AK. All authors have read and accepted the
final manuscript.
Acknowledgements
The work reported in this paper was funded by the Royal Society (UK), the 
Medical Research Council (G0601766) (UK), and the Swedish Council for 
Working Life and Social Research. LS was supported by a British Telecom 
sponsored Dorothy Hodgkin Postgraduate Award. The authors would like 
to thank Ian Lewin for helping to build the first version of the annotation 
tool and Johan Hogberg for supporting the annotation and taxonomy con-
struction work.
References
1. Cohen A, Hersh W: A survey of current work in biomedical
text mining.  Briefings in Bioinformatics 2005, 6:57-71.
2. Ananiadou S, McNaught J: Text Mining for Biology And Biomedicine Nor-
wood, MA, USA: Artech House, Inc; 2005. 
3. Hunter L, Cohen KB: Biomedical Language Processing: What's
Beyond PubMed?  Mol Cell 2006, 21(5):589-594.
4. Ananiadou S, Kell D, Tsujii J: Text mining and its potential appli-
cations in systems biology.  Trends in Biotechnology 2006,
24(12):571-579.
5. Zweigenbaum P, Demner-Fushman D, Yu H, Cohen KB: Frontiers
of biomedical text mining: current progress.  Brief Bioinform
2007, 8(5):358-375.
6. Wilbur WJ, Rzhetsky A, Shatkay H: New directions in biomedical
text annotation: definitions, guidelines and corpus construc-
tion.  BMC Bioinformatics 2006, 7:356.
7. Shatkay H, Pan F, Rzhetsky A, Wilbur WJ: Multi-dimensional clas-
sification of biomedical text: Toward automated, practical
provision of high-utility text to diverse users.  Bioinformatics
2008, 24(18):2086-2093.
8. Karamanis N, Seal R, Lewin I, McQuilton P, Vlachos A, Gasperin C,
Drysdale R, Briscoe E: Natural Language Processing in aid of
FlyBase curators.  BMC Bioinformatics 2008, 9:193.
9. Demaine J, Martin J, Wei L, de Bruijn B: LitMiner: integration of
library services within a bio-informatics application.  Biomedi-
cal Digital Libraries 2006, 3:11.
10. Shah P, Jensen L, Boue S, Bork P: Extraction of transcript diver-
sity from scientific literature.  PLoS Comput Biol 2005, 1:e10.
11. Horn F, Lau AL, Cohen FE: Automated extraction of mutation
data from the literature: application of MuteXt to G protein-
coupled receptors and nuclear hormone receptors.  Bioinfor-
matics 2004, 20(4):557-568.
12. Zweigenbaum P, Demner-Fushman D, Yu H, Cohen KB: New fron-
tiers in biomedical text mining.  Pacific Symposium on Biocomput-
ing 2007:205-208.
13. Muller HM, Kenny EE, Sternberg PW: Textpresso: An Ontology-
Based Information Retrieval and Extraction System for Bio-
logical Literature.  PLoS Biol 2004, 2(11):e309.
14. Cohen KB, Yu H, Bourne PE, Hirschman L: Translating Biol-
ogy:text mining tools that work.  Pacific Symposium on Biocomput-
ing 2008:551-555.
15. Lewin I, Silins I, Korhonen A, Hogberg J, Stenius U: A New Chal-
lenge for Text Mining: Cancer Risk Assessment.  Proceedings of
the ISMB BioLINK Special Interest Group on Text Data Mining 2008.
16. Sun L, Korhonen A, Silins I, Stenius U: User-driven development
of text mining resources for Cancer Risk Assessment.  Pro-
ceedings of the NAACL workshop on BIO-NLP 2009.
17. U.S. Environmental Protection Agency (EPA): Guidelines for carcinogen
risk assessment 2005 [http://www.epa.gov/iris/cancer032505.pdf].
18. European Community Registration, Evaluation, Authorisa-
tion and Restriction of Chemical substances (REACH) legis-
lation   [http://ec.europa.eu/environment/chemicals/reach/pdf/
2007_02_reach_in_brief.pdf]
19. Medical Literature Analysis and Retrieval System Online
[http://www.nlm.nih.gov/databases/databases_medline.html]
20. European Chemicals Agency (ECHA): Guidance on Information Require-
ments and Chemical Safety Assessment. Helsinki 2008.
21. International Agency for Research on Cancer (IARC): Monographs on
the Evaluation of Carcinogenic Risks to Humans Lyon, France; 2006. 
22. Rudén C: The Use and Evaluation of Primary Data in 29
Trichloroethylene Carcinogen Risk Assessments.  Regulatory
Toxicology and Pharmacology 2001, 34:3-16.
23. Rudén C: What influences a health risk assessment?  Toxicology
Letters 2006, 167(3):201-204.
24. Cohen KB, Fox L, Ogren PV, Hunter L: Corpus Design For Bio-
medical Natural Language Processing.  Proceedings of the ACL-
ISMB Workshop on Linking Biological Literature, Ontologies and Databases
2005:38-45.
25. PubMed   [http://www.ncbi.nlm.nih.gov/pubmed]
26. Integrated Risk Information System   [http://cfpub.epa.gov/ncea/
iris/index.cfm]
27. Toxnet Toxicology Data Network   [http://toxnet.nlm.nih.gov/]
28. The Global Portal to Information on Chemical Substances
[http://webnet3.oecd.org/echemportal/]
29. Porter MF: An algorithm for suffix stripping.  Program 1980,
14(3):130-137.
30. Kibriya AM, Frank E, Pfahringer B, Holmes G: Multinomial Naive
Bayes for Text Categorization Revisited.  Australian Conference
on AI 2004, 3339:.
31. Wang H, Huang M, Ding S, Zhu X: Exploiting and integrating rich
features for biological literature classification.  BMC Bioinfor-
matics 2008, 9(Suppl 3):.
32. Han B, Obradovic Z, Hu ZZ, Wu CH, Vucetic S: Substring selec-
tion for biomedical document classification.  Bioinformatics
2006, 22(17):2136-2142.
33. Yang Y, Pedersen JO: A Comparative Study on Feature Selec-
tion in Text Categorization.  In ICML '97: Proceedings of the Four-
teenth International Conference on Machine Learning San Francisco, CA,
USA: Morgan Kaufmann Publishers Inc; 1997:412-420. 
34. Chen YW, Lin CJ: Combining SVMs with Various Feature
Selection Strategies.  In Feature extraction, foundations and applica-
tions Edited by: Guyon I, Gunn S, Nikravesh M, Zadeh L. Berlin/Hei-
delberg: Springer; 2006:315-324. 
35. Rennie JDM, Karger D: Tackling the Poor Assumptions of Naive
Bayes Text Classifiers.  Proceedings of the Twentieth International
Conference on Machine Learning, Washington, DC, USA 2003.
36. Vapnik VN: The nature of statistical learning theory New York, NY, USA:
Springer-Verlag New York, Inc; 1995. 
37. Witten I, Frank E: Data Mining: Practical machine learning tools and tech-
niques 2nd edition. San Francisco: Morgan Kaufmann; 2005. 
38. Yang Y, Liu X: A re-examination of text categorization meth-
ods.  Proceedings of the 22nd SIGIR, New York, NY, USA 1999.
39. Hsu CW, Chang CC, Lin CJ: A practical guide to support vector
classification.  In Tech. rep National Taiwan University, Taipei; 2003. 
40. Fan RE, Chang KW, Hsieh CJ, Wang XR, Lin CJ: LIBLINEAR: A
Library for Large Linear Classification.  Journal of Machine Learn-
ing Research 2008, 9:1871-1874.
41. Cohen J: A Coefficient of Agreement for Nominal Scales.  Edu-
cational and Psychological Measurement 1960, 20:37-46.
42. Artstein R, Poesio M: Inter-coder agreement for computa-
tional linguistics.  Computational Linguistics 2008, 34(4):555-596.
43. Eugenio B, Glass M: The kappa statistic: A second look.  Compu-
tational linguistics 2004, 30:95-101.
44. Siegel S, Castellan N: Nonparametric statistics for the behavioral sciences
McGraw-Hill New York; 1956. 
45. Landis JR, Koch GG: The measurement of observer agreement
for categorical data.  Biometrics 1977, 33:159-174 [http://
view.ncbi.nlm.nih.gov/pubmed/843571].
46. Kim JD, Ohta T, Tsujii J: Corpus annotation for mining biomed-
ical events from literature.  BMC Bioinformatics 2008,
9(10):1471-2105.
47. Chen ES, George H, Hua X, Marianthi M, Friedman C: Automated
acquisition of disease drug knowledge from biomedical and
clinical documents: an initial study.  Journal of the American Med-
ical Informatics Association 2008, 1(15):87-98.
48. Li L, Chase HS, Patel CO, Friedman C, Weng C: Comparing ICD9-
Encoded Diagnoses and NLP-Processed Discharge Summa-
ries for Clinical Trials Pre-Screening: A Case Study.  AMIA
Annual Symposium, Washington, DC, USA 2008.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2009, 10:303 http://www.biomedcentral.com/1471-2105/10/303
Page 19 of 19
(page number not for citation purposes)
49. Wang X, Chused A, Elhadad N, Friedman C, Markatou M: Auto-
mated knowledge acquisition from clinical reports.  AMIA
Annual Symposium 2008.
50. Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S,
Van Criekinge W: PubMeth: a cancer methylation database
combining text-mining and expert annotation.  Nucleic Acids
Research 2008, 36:D842-846.
51. Natarajan J, Berrar D, Dubitzky W, Hack C, Zhang Y, DeSesa C, Van
Brocklyn J, Bremer E: Text mining of full-text journal articles
combined with gene expression analysis reveals a relation-
ship between sphingosine-1-phosphate and invasiveness of a
glioblastoma cell line.  BMC Bioinformatics 2006, 7:373.
52. Lee CH, Chiu HC, Yang HC: A Platform of Biomedical Litera-
ture Mining for Categorization of Cancer Related Abstracts.
In ICICIC '07: Proceedings of the Second International Conference on Inno-
vative Computing, Informatio and Control Washington, DC, USA: IEEE
Computer Society; 2007. 
53. Lee CH, Chiu HC, Yang HC: Text Mining of Clinical Records for
Cancer Diagnosis.  In ICICIC '07: Proceedings of the Second Interna-
tional Conference on Innovative Computing, Informatio and Control Wash-
ington, DC, USA: IEEE Computer Society; 2007. 
54. Medical Subject Headings   [http://www.nlm.nih.gov/mesh/]
55. Nelson S, Powell T, Humphreys B: The Unified Medical Language
System (UMLS) Project.  Encyclopedia of Library and Information Sci-
ence 2002:369-378 [http://www.nlm.nih.gov/research/umls/]. New
York: Marcel Dekker
56. NCBI: EFetch Entrez Utility.  2005 [http://www.ncbi.nlm.nih.gov/
entrez/query/static/efetch_help.html].
57. Blaschko MB, Gretton A: Learning Taxonomies by Dependence
Maximization.  In Twenty-Second Annual Conference on Neural Infor-
mation Processing Systems Edited by: Koller D, Schuurmans D, Bengio
Y, Bottou L. Cambridge, MA, USA: MIT Press; 2009:153-160. 
58. Tsuruoka Y, Tateishi Y, Kim JD, Ohta T, McNaught J, Ananiadou S,
Tsujii J: Developing a Robust Part-of-Speech Tagger for Bio-
medical Text.  In Panhellenic Conference on Informatics, of Lecture
Notes in Computer Science Volume 3746. Edited by: Bozanis P, Houstis
EN. Springer; 2005:382-392. 
59. Corbett P, Batchelor C, Teufel S: Annotation of Chemical
Named Entities.  Proceedings of the ACL, Prague 2007.
60. Yutaka S, Montemagni S, Pezik P, Schuhmann DR, McNaught J, Anani-
adou S: BioLexicon: A Lexical Resource for the Biology
Domain.  Proceedings of the Third International Symposium on Semantic
Mining in Biomedicine (SMBM 2008), Turku, Finland 2008.